These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6441226)

  • 1. Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin.
    Eisenberg JM; Koffer H; Finkler SA
    Rev Infect Dis; 1984; 6 Suppl 4():S909-23. PubMed ID: 6441226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of long-acting cephalosporins in ambulatory therapy.
    Prichard JG
    Clin Ther; 1988; 10(6):688-93. PubMed ID: 3219684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW; McCormack GD; Goodman JS
    Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs and clinical economics: analysis of cost effectiveness in the assessment of pharmaceutical innovations.
    Eisenberg JM
    Rev Infect Dis; 1984; 6 Suppl 4():S905-8. PubMed ID: 6441225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN; Quintiliani R; Nightingale CH
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting.
    Kunkel MJ; Iannini PB
    Rev Infect Dis; 1984; 6 Suppl 4():S865-9. PubMed ID: 6441223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral antibiotic therapy at home: experience with intramuscular cefonicid.
    Nadworny HA; Markowitz A
    Clin Ther; 1987; 10(1):82-91. PubMed ID: 3450394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
    Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic antibiotics for elective colorectal surgery or operation for obstruction of the small bowel: a comparison of cefonicid and cefoxitin.
    Fabian TC; Mangiante EC; Boldreghini SJ
    Rev Infect Dis; 1984; 6 Suppl 4():S896-900. PubMed ID: 6395280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cefonicid use in a general hospital.
    Rodríguez C; Colomé E; Arnau JM; Jodar R; Montoro B; Cano M; Laporte JR
    DICP; 1989 Feb; 23(2):154-6. PubMed ID: 2728506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
    Pontzer RE; Kaye D
    Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and myocardial levels of cefonicid during open-heart surgery.
    Sterling RP; Connor DJ; Norman JC
    J Natl Med Assoc; 1983 Nov; 75(11):1075-80. PubMed ID: 6655710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
    Chambers HF; Mills J; Drake TA; Sande MA
    Rev Infect Dis; 1984; 6 Suppl 4():S870-4. PubMed ID: 6522927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefonicid: an overview of clinical studies in the United States.
    Jacob LS; Layne P
    Rev Infect Dis; 1984; 6 Suppl 4():S791-802. PubMed ID: 6395272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy.
    Maki DG; Lammers JL; Aughey DR
    Rev Infect Dis; 1984; 6 Suppl 4():S887-95. PubMed ID: 6395279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.